Corcept Therapeutics
CORT
CORT
204 hedge funds and large institutions have $1.05B invested in Corcept Therapeutics in 2020 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 72 increasing their positions, 61 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% less funds holding
Funds holding: 205 → 204 (-1)
0.81% less ownership
Funds ownership: 77.94% → 77.13% (-0.81%)
2% less capital invested
Capital invested by funds: $1.08B → $1.05B (-$26.8M)
Holders
204
Holding in Top 10
2
Calls
$6.79M
Puts
$3.44M
Top Buyers
| 1 | +$9.77M | |
| 2 | +$6.36M | |
| 3 | +$6.04M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$5.92M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$5.76M |
Top Sellers
| 1 | -$43.5M | |
| 2 | -$8.03M | |
| 3 | -$6.94M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.69M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$4.69M |